Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Coding Corner Questions: A Drug Administration Quiz

From the College  |  Issue: November 2018  |  November 19, 2018

  1. A 70–year-old female patient with rheumatoid arthritis affecting multiple joints who is rheumatoid-factor positive but without organ or system failure returns for her third infliximab infusion. She is scheduled to receive 500 mg of the drug. How should this encounter be coded?
    1. 96413, 96415, J1745 x 50; ICD 10: M05.79
    2. 96413, 96415, J1745 x 50; ICD 10: M05.69
    3. This encounter cannot be coded without querying the provider
    4. None of the above
  2. A 75-year-old female patient with a diagnosis of postmenopausal osteoporosis without current pathological fracture returns to the practice for her scheduled denosumab injection. She was last seen for an office visit four weeks ago and previously received denosumab six months ago. She is given 60 mg of the drug. How should this encounter be coded?
    1. 96401, J0897 x 60; ICD: M81.0
    2. 99212, 96401, J0897 x 60; ICD 10: M81.1
    3. 96372, J0897 x 60; ICD 10: M81.0
    4. 99212, 96372, J0897 x 60; ICD 10: M8.1
  3. A 66-year-old Medicare patient has a diagnosis of rheumatoid factor-positive rheumatoid arthritis. His disease affects multiple joints, but is associated with no organ involvement, and he returns for his follow-up visit. The history is expanded focused, the exam is problem focused, and the medical decision making is of low complexity. The patient is given an adalimumab injection of 40 mg, because the patient does not like to inject himself. How should this encounter be coded?
    1. 99213-25, 96401, J0135 x 2; ICD 10: M05.79
    2. 99213-25, 96372, J0135 x 2; ICD 10: M05.69
    3. 99213; ICD 10: M05.79
    4. None of the above
  4. A 65-year-old female patient with age-related osteoporosis returns to the practice for her fourth dose of ibandronate sodium, which she receives every 3 months. The dosage is 3 mg. The nurse starts the IV and administers the drug as a bolus over 30 seconds. How should this encounter be coded?
    1. 96401, J1740 x 3; ICD 10: M81.0
    2. 96374, J1740 x 3; ICD 10: M81.0
    3. 96375, J1740 x 3; ICD 10: M81.0
    4. 99211-25, 96374, J1740 x 3; ICD 10: M81.0

Editor’s note: Case vignettes presented in the Coding Corner are created to illustrate questions about coding. They are not intended to represent the full medical record of a case.

Click here for the answer(s).

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Share: 

Filed under:Billing/CodingFrom the College Tagged with:adalimumabBilling & Codingdenosumabibandronate sodiuminfliximab

Related Articles
    Prepare NOW for ICD-10 Medical Coding Transition

    Prepare NOW for ICD-10 Medical Coding Transition

    July 14, 2015

    The ICD-10 page on the Centers for Medicare & Medicaid Services (CMS) website features a countdown clock that shows the time left until Oct. 1, 2015, the date on which compliance with the new code set becomes mandatory. By the time this issue goes to press, the clock will read 90 or fewer days. Time…

    2013–A Whole New World

    May 16, 2011

    ICD-10 will change the coding and billing landscape, and practices should start preparing now

    Plan Now for ICD-10 Changeover

    May 16, 2011

    Coding changes will have an impact on staff, physicians, and even the finances of rheumatology practices

    ICD-10 Adoption Brings Major Changes to Practices

    January 17, 2011

    Change will affect all facets of a rheumatology practice, from front desk to doctor charting to finances

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences